| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.086 | 0.1 |